8 Best 3d Printing for November 2025
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Market Overview & Selection Criteria
The current market environment is characterized by heightened volatility and a renewed focus on fundamental value. Investors are increasingly seeking companies with strong balance sheets, robust free cash flow, and clear growth catalysts. Our selection methodology leverages ValueSense’s proprietary intrinsic value models, quality ratings, and sector analysis to identify stocks that are undervalued relative to their long-term potential[1][2]. Each stock featured below was screened for financial health, growth prospects, and sector diversification, using a blend of quantitative and qualitative analysis.
Featured Stock Analysis
Autodesk, Inc. (ADSK)
| Metric | Value |
|---|---|
| Market Cap | $64.2B |
| Quality Rating | 7.0 |
| Intrinsic Value | $236.3 |
| 1Y Return | 6.2% |
| Revenue | $6,599.0M |
| Free Cash Flow | $1,923.0M |
| Revenue Growth | 13.7% |
| FCF margin | 29.1% |
| Gross margin | 90.8% |
| ROIC | 19.8% |
| Total Debt to Equity | 100.7% |
Investment Thesis
Autodesk stands out as a global leader in design and engineering software, serving industries from architecture to manufacturing. With a market cap of $64.2B and a quality rating of 7.0, Autodesk demonstrates both scale and operational excellence. Its intrinsic value of $236.3 suggests potential upside relative to current market pricing. The company’s 13.7% revenue growth and 90.8% gross margin highlight its ability to scale profitably, while a free cash flow margin of 29.1% and ROIC of 19.8% underscore efficient capital allocation.
Key Catalysts
- Continued adoption of cloud-based design tools across industries
- Expansion into construction and manufacturing verticals
- Strong recurring revenue from subscription-based business model
- High gross margins supporting reinvestment in R&D
Risk Factors
- Elevated total debt to equity 100.7% could pressure flexibility in downturns
- Competitive threats from emerging SaaS design platforms
- Sensitivity to macroeconomic cycles in construction and manufacturing
Xometry, Inc. (XMTR)
| Metric | Value |
|---|---|
| Market Cap | $2,459.7M |
| Quality Rating | 5.3 |
| Intrinsic Value | $40.3 |
| 1Y Return | 147.4% |
| Revenue | $603.8M |
| Free Cash Flow | ($20.5M) |
| Revenue Growth | 20.2% |
| FCF margin | (3.4%) |
| Gross margin | 39.1% |
| ROIC | (12.3%) |
| Total Debt to Equity | 123.4% |
Investment Thesis
Xometry is a digital marketplace for on-demand manufacturing, connecting buyers with a global network of suppliers. With a market cap of $2.46B and a quality rating of 5.3, Xometry has delivered a remarkable 1-year return of 147.4%. The company’s 20.2% revenue growth signals strong demand for its platform, though negative free cash flow (–$20.5M) and a ROIC of –12.3% reflect ongoing investment in scaling operations.
Key Catalysts
- Rapid expansion of the digital manufacturing ecosystem
- Increasing adoption by enterprise customers seeking supply chain flexibility
- Potential for margin improvement as scale increases
Risk Factors
- Negative free cash flow and profitability metrics may persist near-term
- Total debt to equity 123.4% is relatively high for a growth-stage company
- Execution risk as the company scales internationally
Proto Labs, Inc. (PRLB)
| Metric | Value |
|---|---|
| Market Cap | $1,188.7M |
| Quality Rating | 6.1 |
| Intrinsic Value | $38.6 |
| 1Y Return | 81.6% |
| Revenue | $518.4M |
| Free Cash Flow | $75.8M |
| Revenue Growth | 2.8% |
| FCF margin | 14.6% |
| Gross margin | 44.1% |
| ROIC | 1.5% |
| Total Debt to Equity | 0.4% |
Investment Thesis
Proto Labs specializes in rapid prototyping and on-demand manufacturing, serving a diverse industrial client base. With a market cap of $1.19B and a quality rating of 6.1, the company has posted a strong 1-year return of 81.6%. Its free cash flow margin of 14.6% and ROIC of 1.5% indicate operational resilience, while a total debt to equity of just 0.4% signals a conservative capital structure.
Key Catalysts
- Growth in demand for rapid prototyping and small-batch manufacturing
- Expansion of digital manufacturing services and automation
- Strong balance sheet supports reinvestment and innovation
Risk Factors
- Slower revenue growth 2.8% compared to peers
- Competitive pressures from both traditional and digital manufacturers
- Margin compression risk in a cyclical downturn
Stratasys Ltd. (SSYS)
| Metric | Value |
|---|---|
| Market Cap | $886.6M |
| Quality Rating | 5.0 |
| Intrinsic Value | $14.4 |
| 1Y Return | 48.5% |
| Revenue | $564.5M |
| Free Cash Flow | ($11.9M) |
| Revenue Growth | (6.0%) |
| FCF margin | (2.1%) |
| Gross margin | 44.9% |
| ROIC | (9.3%) |
| Total Debt to Equity | 3.4% |
Investment Thesis
Stratasys is a pioneer in 3D printing solutions, targeting industries from aerospace to healthcare. With a market cap of $886.6M and a quality rating of 5.0, Stratasys has delivered a 1-year return of 48.5%. Despite a 6.0% decline in revenue, the company maintains a gross margin of 44.9%, reflecting pricing power in niche markets.
Key Catalysts
- Ongoing innovation in additive manufacturing technologies
- Strategic partnerships in aerospace and medical devices
- Potential for turnaround as demand for 3D printing accelerates
Risk Factors
- Negative free cash flow and declining revenue growth
- ROIC of –9.3% indicates operational challenges
- Modest leverage but limited margin for error in execution
3D Systems Corporation (DDD)
| Metric | Value |
|---|---|
| Market Cap | $378.3M |
| Quality Rating | 5.4 |
| Intrinsic Value | $10.8 |
| 1Y Return | -4.7% |
| Revenue | $413.3M |
| Free Cash Flow | ($82.9M) |
| Revenue Growth | (9.1%) |
| FCF margin | (20.1%) |
| Gross margin | 35.1% |
| ROIC | (79.4%) |
| Total Debt to Equity | 80.5% |
Investment Thesis
3D Systems is a legacy player in the 3D printing industry, with a market cap of $378.3M and a quality rating of 5.4. The company has faced headwinds, with a 1-year return of –4.7% and revenue decline of 9.1%. Its gross margin of 35.1% and free cash flow margin of –20.1% highlight ongoing profitability challenges, while a ROIC of –79.4% signals deep operational issues.
Key Catalysts
- Restructuring efforts to streamline operations
- Potential asset sales or strategic partnerships
- Industry consolidation could unlock shareholder value
Risk Factors
- Persistent negative free cash flow and high leverage (total debt to equity 80.5%)
- Competitive threats from more agile 3D printing firms
- Uncertain path to sustainable profitability
Materialise NV (MTLS)
| Metric | Value |
|---|---|
| Market Cap | $378.0M |
| Quality Rating | 5.1 |
| Intrinsic Value | $18.4 |
| 1Y Return | 8.3% |
| Revenue | $274.7M |
| Free Cash Flow | $1,998.0K |
| Revenue Growth | 3.5% |
| FCF margin | 0.7% |
| Gross margin | 56.5% |
| ROIC | 2.1% |
| Total Debt to Equity | 0.0% |
Investment Thesis
Materialise is a Belgium-based provider of 3D printing software and services, with a market cap of $378.0M and a quality rating of 5.1. The company’s 1-year return of 8.3% and revenue growth of 3.5% reflect steady, if unspectacular, progress. Materialise boasts a gross margin of 56.5% and a free cash flow margin of 0.7%, indicating disciplined cost management.
Key Catalysts
- Expansion in healthcare and industrial 3D printing applications
- Strong software IP and recurring revenue streams
- Zero debt (total debt to equity 0.0%) provides financial flexibility
Risk Factors
- Modest revenue growth relative to sector peers
- Currency and geopolitical risks as a European operator
- Need for continued innovation to maintain competitive edge
Monogram Orthopaedics, Inc. (MGRM)
| Metric | Value |
|---|---|
| Market Cap | $213.1M |
| Quality Rating | 5.9 |
| Intrinsic Value | $1.3 |
| 1Y Return | 158.6% |
| Revenue | $0.0 |
| Free Cash Flow | ($7,562.7K) |
| Revenue Growth | (100.0%) |
| FCF margin | N/A |
| Gross margin | N/A |
| ROIC | 2,212.7% |
| Total Debt to Equity | 3.4% |
Investment Thesis
Monogram Orthopaedics is an early-stage medical device company focused on orthopedic implants. With a market cap of $213.1M and a quality rating of 5.9, Monogram has delivered a 1-year return of 158.6% despite reporting zero revenue and negative free cash flow (–$7.56M). The company’s ROIC of 2,212.7% is an outlier, likely reflecting early-stage accounting effects rather than sustainable profitability.
Key Catalysts
- Breakthroughs in personalized orthopedic implant technology
- Regulatory approvals and initial commercialization milestones
- High investor interest in medtech innovation
Risk Factors
- No current revenue; business model remains unproven
- High cash burn and reliance on external funding
- Execution and regulatory risks typical of early-stage medtech
Boxlight Corporation (BOXL)
| Metric | Value |
|---|---|
| Market Cap | $5,009.9K |
| Quality Rating | 5.5 |
| Intrinsic Value | $114.2 |
| 1Y Return | -30.8% |
| Revenue | $113.6M |
| Free Cash Flow | $3,675.0K |
| Revenue Growth | (30.8%) |
| FCF margin | 3.2% |
| Gross margin | 33.8% |
| ROIC | (28.4%) |
| Total Debt to Equity | 684.2% |
Investment Thesis
Boxlight is a micro-cap provider of interactive technology solutions for education, with a market cap of $5.01M and a quality rating of 5.5. The company has struggled, with a 1-year return of –30.8% and revenue decline of 30.8%. Despite these challenges, Boxlight maintains a free cash flow margin of 3.2% and a gross margin of 33.8%, suggesting some operational resilience.
Key Catalysts
- Potential for turnaround as schools increase technology adoption
- New product launches and partnerships in the edtech space
- Micro-cap status could attract speculative interest
Risk Factors
- High leverage (total debt to equity 684.2%) and declining revenues
- Intense competition from larger, better-capitalized edtech firms
- Risk of delisting or further capital dilution
Portfolio Diversification Insights
This collection spans technology, industrials, healthcare, and education, offering exposure to both established leaders (Autodesk) and high-growth disruptors (Xometry, Monogram Orthopaedics). The inclusion of 3D printing specialists (Stratasys, 3D Systems, Materialise, Proto Labs) provides thematic diversification within advanced manufacturing. Micro-cap and early-stage companies (Boxlight, Monogram) add speculative upside but increase risk, while larger, cash-generative firms (Autodesk, Proto Labs) anchor the portfolio with stability.
Market Timing & Entry Strategies
Given the volatility in growth and tech sectors, consider phased entry strategies such as dollar-cost averaging to mitigate timing risk. Monitor earnings releases, sector news, and macroeconomic indicators for optimal entry points. For speculative or micro-cap names, position sizing and stop-loss strategies can help manage downside risk. Use ValueSense’s intrinsic value tools to compare current prices against fair value estimates before initiating positions[1][2].
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2025)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!
More Articles You Might Like
- How VKTX (Viking Therapeutics) Makes Money in 2025: A Deep-Dive With Income Statement
- How NET (Cloudflare) Makes Money in 2025: A Deep-Dive With Income Statement
- How MASS (908 Devices) Makes Money in 2025: A Deep-Dive With Income Statement
- How CRVO (CervoMed) Makes Money in 2025: A Deep-Dive With Income Statement
- How GILD (Gilead Sciences) Makes Money in 2025: A Deep-Dive With Income Statement
FAQ Section
Q1: How were these stocks selected?
Stocks were chosen using ValueSense’s proprietary screening tools, focusing on intrinsic value, quality ratings, financial health, and sector diversification. The process combines quantitative metrics with qualitative analysis of growth catalysts and risks[1][2].
Q2: What's the best stock from this list?
No single stock is universally “best,” but Autodesk (ADSK) stands out for its high quality rating, strong free cash flow, and leadership in design software. However, high-growth names like Xometry (XMTR) and Monogram Orthopaedics (MGRM) offer significant upside potential, albeit with higher risk.
Q3: Should I buy all these stocks or diversify?
Diversification across sectors and company sizes can help manage risk. This watchlist is designed to provide a balanced mix of established leaders and emerging innovators, allowing investors to tailor allocations based on their risk tolerance and investment goals.
Q4: What are the biggest risks with these picks?
Key risks include negative free cash flow in several companies, high leverage (notably Boxlight and Xometry), and sector-specific challenges such as competition and regulatory hurdles. Early-stage and micro-cap stocks carry additional volatility and liquidity risks.
Q5: When is the best time to invest in these stocks?
Optimal timing depends on individual stock valuations, earnings cycles, and market conditions. Using tools like ValueSense’s intrinsic value calculator and monitoring sector news can help identify attractive entry points. Dollar-cost averaging is a prudent strategy for volatile or speculative names.